Page last updated: 2024-08-23

simvastatin and Fetal Death

simvastatin has been researched along with Fetal Death in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Franzke, CW; Girardi, G; Mackman, N; Redecha, P; Ruf, W1
Burnett, DM; Cunningham, ML; Osborne, MJ; Pollack, PS; Shields, KE; Stepanavage, ME1

Other Studies

2 other study(ies) available for simvastatin and Fetal Death

ArticleYear
Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
    The Journal of clinical investigation, 2008, Volume: 118, Issue:10

    Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Disease Models, Animal; Factor VIIa; Female; Fetal Death; Gene Deletion; Gene Expression Regulation; Humans; Immunoglobulin G; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Activation; Neutrophils; Phagocytosis; Pregnancy; Reactive Oxygen Species; Receptor, PAR-1; Receptor, PAR-2; Respiratory Burst; Signal Transduction; Simvastatin; Thromboplastin

2008
Pregnancy outcomes after maternal exposure to simvastatin and lovastatin.
    Birth defects research. Part A, Clinical and molecular teratology, 2005, Volume: 73, Issue:11

    Topics: Abnormalities, Drug-Induced; Abortion, Spontaneous; Adult; Anticholesteremic Agents; Female; Fetal Death; Humans; Lovastatin; Maternal-Fetal Exchange; Pregnancy; Pregnancy Outcome; Prospective Studies; Retrospective Studies; Simvastatin

2005